About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Papers In This Journal Are Just So Darn Relevant | Main | Scientist Shortage? The Media Starts to Catch On. »

July 6, 2012


Email This Entry

Posted by Derek

I wanted to let everyone know that I'll be taking a summer break - as of yesterday, I've cleared myself and my family out of the house and off for some R&R. I'll be lounging around all next week, and will return to blogdom (and research-dom) on Monday the 16th. I've already told folks in the lab not to discover anything gigantic while I'm gone (it looks bad, y'know).

Comments (9) + TrackBacks (0) | Category: Blog Housekeeping


1. kitten_mittons on July 6, 2012 2:25 PM writes...

enjoy your time off :)

Permalink to Comment

2. jackgg on July 6, 2012 11:25 PM writes...

You are funny. Have fun!

Permalink to Comment

3. newnickname on July 7, 2012 7:46 PM writes...

From today's Washington Post, front page (on-line version):

"U.S. pushes for more scientists, but the jobs aren’t there." By Brian Vastag, Saturday, July 7,

... "The pharmaceutical industry once offered a haven for biologists and chemists who did not go into academia. Well-paying, stable research jobs were plentiful in the Northeast, the San Francisco Bay area and other hubs. But a decade of slash-and-burn mergers; stagnating profit; exporting of jobs to India, China and Europe; and declining investment in research and development have dramatically shrunk the U.S. drug industry, with research positions taking heavy hits. ..."

"... Haas, the former drug company chemist, has even harsher words. She plans to “get out of Jersey and get out of science” when her daughter graduates from high school in two years. “She’s very good at everything, very smart,” Haas said of her daughter. “She loves chemistry, loves math. I tell her, ‘Don’t go into science.’ I’ve made that very clear to her.”"

Permalink to Comment

4. gippgig on July 8, 2012 12:01 AM writes...

This article may be of interest:
Taking a chance
Assuming a larger role in drug discovery means greater risks-and possibly greater rewards.
The Washington Post ran yet another of those no jobs for scientists articles:

Permalink to Comment

5. gippgig on July 8, 2012 3:40 AM writes...

Oops, that 2nd address doesn't work - but it's the address shown by that web page! Anyone have any idea why?

Permalink to Comment

6. LR on July 8, 2012 4:32 PM writes...

Re the Washington Post article -

As of 11 am this morning, there were 2400 comments on the Post website regarding this article. As of 5 pm, there were 3500 comments. Apparently this article has struck a nerve.

Hopefully the author of this blog will be able to post about the article and its implications while he is on vacation.

Permalink to Comment

7. dearieme on July 8, 2012 6:51 PM writes...

‘Don’t go into science.’ OK, but what should she go into?

Permalink to Comment

8. Chemjobber on July 8, 2012 10:04 PM writes...

I have written up a post on the Vastag article that I have linked in my handle. If you would like to discuss it over there, come on over!

Permalink to Comment

9. UpNorth on July 9, 2012 7:56 AM writes...

If the girl's good, she can do pretty much anything she wants to. Something like medicine is a reasonable alternative to science or engineering, assuming the expense isn't too great. Can do law or finance if cash is king, or even go for academia.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry